One study showed a significant trend in the proportion of p53 reactivity from keratoacanthomas to poorly differentiated squamous cell carcinomas, although p53 reactivity could not reliably distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma [10]. This evidence concerns the gene TP53 and squamous cell carcinoma.